Chimerix
phase efficacy for in recurrent | Chimerix
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
7 of 43
Similar slides by Chimerix
See diffirences between slides (animation)
Investor Presentation
May 2023
phase efficacy for in recurrent | Chimerix
Investor Presentation
March 2023
phase efficacy for in recurrent | Chimerix
Investor Conference
November 2021
summary | Chimerix
Investor Conference
November 2021
summary | Chimerix
Related slides by other companies
Neumora Therapeutics
IPO
September 2023
phase efficacy population patient demographics and characteristics similar across treatment groups | Neumora Therapeutics
Matinas BioPharma
Investor Presentation
January 2024
enact phase clinical validation of safety and efficacy | Matinas BioPharma
MAIA Biotechnology
Investor Presentation
July 2023
thio trial patients dosed to date | MAIA Biotechnology
GH Research
Investor Presentation
March 2023
phase single dose efficacy | GH Research
Other recent decks by Chimerix
See all presentations (6 decks)
Investor Presentation
May 2023
Investor Presentation
March 2023
Results
March 2022
Investor Conference
November 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights